MARSHALL BELAGA: Open Payments
NPI 1568492478 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$976 in 26 payments from 12 companies in 2025. Trend: 2023 $952 · 2024 $287 · 2025 $976
Food & beverage: $976
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 7 | $307 |
| Janssen Pharmaceuticals, Inc | 1 | $125 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $124 |
| Alkermes, Inc. | 3 | $94 |
| Otsuka America Pharmaceutical, Inc. | 4 | $86 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $60 |
| Teva Pharmaceuticals USA, Inc. | 2 | $51 |
| E.R. Squibb & Sons, L.L.C. | 2 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Corium, LLC | 1 | $23 |
Products named: Auvelity, SPRAVATO, LUMRYZ, ARISTADA, ABILIFY MAINTENA, CAPLYTA, AUSTEDO XR, COBENFY.
Industry payments across MS — which companies pay providers there.
